Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by G Lania
miR-194-5p/BCLAF1 Deregulation in AML Tumorigenesis
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
Tumor Suppressive Role of miR-194-5p in Glioblastoma Multiforme
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
The Clinical Significance of Downregulation of Mir-124-3p, Mir-146a-5p, Mir-155-5p and Mir-335-5p in Gastric Cancer Tumorigenesis
International Journal of Oncology
Cancer Research
Oncology
Figure 6: Quantitative PCR Analysis of miR-26a-5p, miR-181a-5p, miR-34a-5p, miR-93-5p, Pten, Creb, BCL-2, and Sirt1 Expression in miR-26a-5p (A), miR-181a-5p (B), miR-34a-5p (C), miR-93-5p (D) Mimic Transfected HUVECs.
Downregulation of miR-194-5p Induces Paclitaxel Resistance in Ovarian Cancer Cells by Altering MDM2 Expression
Oncotarget
Oncology
microRNA-342-5p and miR-608 Inhibit Colon Cancer Tumorigenesis by Targeting NAA10
Oncotarget
Oncology
CircDUSP16 Promotes the Tumorigenesis and Invasion of Gastric Cancer by Sponging miR-145-5p
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
PPARGEpigenetic Deregulation and Its Role in Colorectal Tumorigenesis
PPAR Research
Drug Discovery
Pharmacology
Combined Detection of miR-21-5p, miR-30a-3p, miR-30a-5p, miR-155-5p, miR-216a and miR-217 for Screening of Early Heart Failure Diseases
Bioscience Reports
Biochemistry
Cell Biology
Molecular Biology
Biophysics
MiR-542-5p Is a Negative Prognostic Factor and Promotes Osteosarcoma Tumorigenesis by Targeting HUWE1
Oncotarget
Oncology